Articles tagged with Cancer Patients
Researchers have identified collagen features as valuable biomarkers for evaluating melanoma immunotherapy response. Single-fiber characteristics were found to be more sensitive to treatment-induced changes than bulk collagen features, offering insights into collagen remodeling over time.
The study found a 5.7% blood culture positive rate among eligible Hem-Onc patients, with 56% having an absolute neutrophil count greater than 500 µL at presentation. Gram-positive organisms were the most common isolates, highlighting the diversity of bloodstream infection causes in this patient population.
Patients living far from comprehensive cancer centers (CCC) have higher odds of receiving late-stage cancer diagnoses. Non-Hispanic Black patients and those with no insurance also experience disparities in cancer staging. CCCs can improve outcomes by adopting standardized catchment area assessments and sharing patient care information.
A Kaiser Permanente study of 316,443 patients reveals that 7.4% repeated fecal testing instead of proceeding to a colonoscopy, and only 41% received a colonoscopy within one year of their initial positive test. Patients who repeated home tests cited concerns about colorectal cancer diagnosis
Researchers found low rates of metastasis and lymph node involvement in post-menopausal patients with early-stage ER+ breast cancer. This suggests that clinical guidelines for de-escalating surgery may be safely extended to younger patients.
A study of nearly 5,000 mammograms found that AI algorithms produced false positive results more frequently in Black and older patients, while Asian patients and younger patients were less likely to be flagged as suspicious. Healthcare institutions should consider the patient population they serve before purchasing an AI algorithm.
The FDA committee voted unanimously to approve minimal residual disease (MRD) as a new clinical endpoint for evaluating proposed drugs to treat multiple myeloma. A meta-analysis led by C. Ola Landgren shows a strong correlation between MRD and clinical outcomes in newly diagnosed and relapsed patients.
A cross-sectional study reveals racial and ethnic disparities in treatment delays and discontinuations among patients with SARS-CoV-2, leading to increased cancer mortality among minoritized adults. The disproportionate burden varied across SARS-CoV-2 waves.
A new questionnaire assesses sexual health concerns in female partners of prostate cancer patients, highlighting challenges with communication and feelings of isolation. The study reveals high levels of distress and depression among these women.
Researchers found that blocking PI3K-beta makes glioblastoma cells more sensitive to temozolomide treatment, slowing down tumor growth. The study's findings could lead to new treatments for patients with chemotherapy-resistant glioblastoma.
Researchers found no significant 'participation effect' in cancer trials, contrary to common belief among patients and healthcare providers. The study's results provide reassurance that not enrolling in a trial doesn't disadvantage a patient's survival outcomes.
The American Gastroenterological Association recommends considering endoscopic eradication therapy for patients with low-grade dysplasia after discussing risks and benefits. For patients with high-grade dysplasia, the AGA suggests removing abnormal pre-cancerous cells to reduce esophageal cancer mortality.
Researchers used AI to detect localized versus advanced cancer stages in oropharyngeal squamous cell carcinoma patients. The study suggests improved patient care and clinical decision-making through AI-assisted health record extraction.
The American Society for Radiation Oncology's (ASTRO) 66th Annual Meeting will be held in Washington, D.C., featuring over 170 exhibitors showcasing state-of-the-art cancer care technologies. Registered attendees can access livestreams of scientific and educational sessions, both in-person and virtually.
Researchers found that ARID1A mutation renders tumors sensitive to immunotherapy by triggering an antiviral immune response. This could lead to improved patient outcomes and the development of targeted therapies.
A Mayo Clinic study of 492,597 patients with melanoma found that Black men are more likely to be diagnosed at later stages and experience worse outcomes due to the disease. In contrast, Black female patients fared better, with a higher survival rate for stage 3 melanoma.
A study published in Blood Neoplasia reveals that older adults with acute myeloid leukemia can benefit from standard treatment, with roughly a quarter experiencing durable prolonged survival. The conventional treatment of venetoclax combined with a hypomethylating agent (HMA) is safe and effective for those over 80 years old.
Researchers at UCLA Health Jonsson Comprehensive Cancer Center have found a combination immunotherapy treatment that enhances the immune response for people with malignant gliomas. Adding an immune-boosting agent, poly-ICLC, to a personalized dendritic cell vaccine improves the immune response and activity of T cells in patients.
A cross-sectional study found racial and ethnic disparities in breast cancer treatment declination and overall survival. The study suggests that patient education on treatment benefits and improved communication between patients and clinicians can help reduce disparities and improve patient outcomes.
Researchers developed a Pix-2-Pix GAN model to correct PSMA PET/CT images, improving image quality and quantitative markers. The AI-generated images show high correlation with original images and potential for reducing CT scans without compromising image quality.
A third Covid vaccine dose has been shown to improve defensive antibody responses in some clinically extremely vulnerable patients. The trial found that 90% of patients who received a booster dose developed significant antibodies, but more than half of those with low initial responses saw no improvement.
A multidisciplinary team of Caribbean authors has developed innovative solutions to safeguard cancer patients from climate-driven disasters. The research highlights the urgent need for climate-resilient healthcare infrastructure in developing regions.
A novel investigational PET imaging agent, <sup> 68 </sup> Ga-DPI-4452 (Debio 0328), has been shown to provide rapid and accurate visualization of lesions in clear cell renal cell cancer patients. The agent offers a superior alternative to standard CT imaging and could potentially be used as part of a theranostic pair.
A late University of Virginia School of Medicine scientist's research on the SAS1B protein could lead to new cancer treatments for multiple cancers. The discovery has the potential to selectively target cancer cells while sparing healthy tissue.
A nationwide training program aims to equip clinicians with digital tools for targeted fatigue, insomnia, pain, depression, and anxiety in cancer patients. The project will train 600 clinicians in technology-augmented care.
The summit aimed to improve care for people with cancer by discussing knowledge gaps, societal stigma, and shifting policies. Experts emphasized the importance of education about sexual and reproductive health in cancer treatment.
The PSMAfore study found that 177Lu-PSMA-617 prolonged radiographic progression-free survival and improved PSA response rate compared to a change in ARPI. Treatment with 177Lu-PSMA-617 also increased objective response rate, regardless of prior treatment.
A study published by University of Pittsburgh researchers found that ACA insurance expansions led to an increase in patients receiving care at accredited cancer hospitals in Pennsylvania. The study suggests that these expansions make a difference in improving access to high-quality cancer care, particularly for those living in areas wi...
The prevalence of lung cancer mutations varies significantly across different ethnic groups in Latin America, highlighting the need for region-specific medical interventions. Enhancing molecular diagnostic and research efforts is crucial for effective management of cancer in this population.
Glioblastoma cancer cells change their appearance and behavior to evade T-cell attack, rendering immunotherapy ineffective. Researchers found that these 'plastic' cells can also exhaust T-cells, making glioblastoma resistant to treatment.
Researchers found a strong association between favorable survival outcomes and high populations of tissue-resident memory T cells in melanoma patients. The study identified 11 distinct gene signatures that correlate with T cell abundance and patient survival, suggesting a crucial role for T cells in immunomodulation.
A new study published in JAMA Oncology highlights the importance of testing for measurable residual disease (MRD) in patients with acute myeloid leukemia (AML) undergoing bone marrow transplants. The researchers found that detecting MRD can help predict cancer recurrence and improve patient outcomes.
A new AI model developed by researchers at the University of British Columbia can accurately predict if a patient receiving cancer care will require mental health services. The AI analyzes oncologist's notes and identifies subtle clues that suggest a patient may benefit from early psychiatric or counselling interventions.
A new mRNA cancer vaccine has been shown to trigger a vigorous immune response in both human patients and pet dogs with glioblastoma, the most aggressive form of brain cancer. The breakthrough treatment, which uses a personalized approach and novel delivery mechanism, demonstrates promising results in early clinical trials.
A study by the Maine Cancer Genomics Initiative (MCGI) found that 17% of patients received genome-matched treatment, resulting in a 31% reduced mortality rate within one year. However, only 9% participated in clinical trials, highlighting the need to improve access and delivery of precision oncology care.
Men with prostate cancer who listened to mindfulness audio recordings during radiation therapy experienced significant reductions in fatigue, sleep problems, anxiety, and depressive symptoms. The study found that the mindfulness intervention was more effective than listening to relaxing music during treatment.
A new set of clinical practice standards and recommendations offers tailored and effective care for individuals with advanced and metastatic cancer. The initiative, backed by MASCC and ASCO, provides a critical resource to healthcare stakeholders.
A study of 15 brand-name drugs found that competition from 'skinny label' generics saved Medicare nearly $15 billion from 2015 to 2021. The largest savings were seen for rosuvastatin, pregabalin, and imatinib, with actual spending being $16.8 billion versus projected spending of $31.5 billion.
A randomized clinical trial of 3,020 patients with high-risk nonmetastatic breast cancer found daily aspirin therapy had no effect on breast cancer recurrence or survival in early follow-up. Aspirin should not be recommended as an adjuvant breast cancer treatment despite its potential benefits and wide availability
Researchers at the University of Leipzig Medical Center have identified biomarkers associated with the response to CAR T cell therapy in multiple myeloma. These biomarkers enable patients to predict their likelihood of responding well or less well to treatment before initiating therapy.
A new study by the American Cancer Society found that cancer survivors reporting loneliness experience a higher mortality risk compared to those with low or no loneliness. The study identified a dose-response association between loneliness levels and mortality risk, with the highest risk among those experiencing severe loneliness.
Researchers at TUM have uncovered a mechanism by which tumor cells prevent the formation of immune responses, including cytotoxic T cells. This discovery provides rationales for new cancer immunotherapies and could enhance existing treatments.
MIT engineers have developed a closed-loop drug-delivery system that can improve chemotherapy outcomes by continuously monitoring patients and adjusting dosage. The new system, called CLAUDIA, uses commercially available equipment to analyze blood samples every five minutes and adjust infusion rates in real-time.
A new study published in the Journal of Clinical Oncology identified NECTIN4 amplification as a potential genomic biomarker for predicting treatment response to enfortumab vedotin in patients with advanced urothelial carcinoma. The study found that over 90% of patients with NECTIN4 amplification showed tumor response to EV therapy.
A new study by the American Cancer Society highlights the financial impact of a cancer diagnosis on working-age adults, leading to employment disruptions and loss of household income. Nearly 60% of working-age cancer survivors report at least one type of financial hardship.
Patients who quit smoking before starting chemotherapy or radiation responded better to treatment, were less likely to need their voice boxes surgically removed, and lived significantly longer than those who continued to smoke. Quitting smoking also improved quality of life for seven years after treatment.
The FDA has approved the use of N-803, an immunotherapy drug, in combination with BCG for treating patients with non-muscle invasive bladder cancer who did not respond to conventional treatment. The approval is based on a trial led by UCLA's Dr. Karim Chamie, which showed improved outcomes and longer overall survival rates.
A new clinical trial reveals that a novel writing therapy can significantly reduce cancer-related trauma, depression, anxiety, and hopelessness in late-stage cancer patients. By confronting their greatest fears through written exposure-based coping (EASE), participants experience improved mental well-being.
A new AI-based approach, PERCEPTION, uses single-cell transcriptomics to predict patient response to cancer drugs and monitor resistance. The approach was validated in three clinical trials for multiple myeloma, breast, and lung cancer, with promising results.
Researchers discovered that mutations in noncoding regions of cancer-driving genes can alter mRNA abundance, leading to increased or decreased protein production. This discovery may lead to the development of prognostic testing tools and a better understanding of gene regulation mechanisms in cancer progression.
The innovative Integrated Virtual Care (IVC) program successfully connected residents with family physicians in Renfrew County, addressing the rural shortage of primary care providers. Over 2,800 unique patient appointments were conducted, with 70% done virtually, offering comprehensive team-based primary care.
A national cohort study found that neighborhood disadvantage was independently associated with shorter breast cancer–specific survival. The study suggests potential unaccounted-for mechanisms, including both nonbiologic and biologic factors, and highlights the need for further research.
Only 4% of cancer survivors met all four American Cancer Society guidelines, with a mean of 2.0 guidelines met. This study aims to improve understanding of guideline adherence and inform recommendations for patients who have completed cancer treatments.
A study by the University of Gothenburg found that women with triple-negative breast cancer and high immune cell levels have a lower relapse risk after surgery. This suggests that these patients may not need chemotherapy, despite having faster-growing tumors and higher relapse rates than other breast cancers.
Researchers at the University of Pittsburgh have discovered how to overcome resistance to conventional immunotherapies in metastatic uveal melanoma. They developed a clinical tool called Uveal Melanoma Immunogenic Score (UMIS) to predict patient response and improve treatment outcomes.
A new study developed two machine learning models to quantify CD8+ cell positivity and classify the immunophenotype of cancer specimens in patients with non-small cell lung cancer. The models hold promise for identifying patients who may benefit from immunotherapy.
The PRECEDE study found that nearly 80% of participants in the highest-risk cohort completed baseline imaging, highlighting the feasibility of improving early detection and prevention for pancreatic cancer. Researchers recommend sorting individuals into three groups based on family history and genetic mutations to tailor surveillance.
A new Lancet Commission reveals that many people with breast cancer are being systematically left behind due to inaction on inequities and hidden suffering. The commission highlights the need for better patient support, including improved communication between patients and healthcare professionals.
Researchers have developed a new treatment that uses tailored doses of anti-cancer drugs released directly into the surgical cavity to treat liver cancer. The approach has shown promise in reducing recurrence rates and minimizing chemotherapy side effects, with potential applications for other types of cancer.
A groundbreaking treatment approach that combines genetic testing with individualized drug testing on tumor samples has shown promising results in treating relapsed pediatric cancer patients. The study achieved an impressive 83% improvement rate, including Logan Jenner's successful treatment after his leukemia relapse.